According to a new market research study of “Asia Pacific Continuous Positive Airway Pressure (CPAP) Devices Market Forecast to 2027 - COVID-19 Impact and Analysis by Type and End User, the Asia Pacific continuous positive airway pressure (CPAP) devices is projected to reach US$ 837.58 million by 2027 from US$ 438.35 million in 2019. The market is estimated to grow at CAGR of 8.5% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific continuous positive airway pressure (CPAP) devices market and the factors driving market along with those that act as hindrances.
Based on type, the Asia Pacific continuous positive airway pressure (CPAP) devices market is further segmented into automatic and manual. The automatic segment held the larger share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. Automatic or Auto CPAP are initially used for pressure titration. Automatic titrating (measuring and adjusting) continuous positive airway pressure is also known as APAP. Auto-CPAP is set within a high and low-pressure range for the purpose of varying inhalation needs. This range is predetermined by prescribing physician. Additionally, this technology has a sensitive algorithm that allows the machine to detect the inhalation pressure which patients need with each breath. Thus, owing to above mentioned reasons, the market for automatic continuous positive airway pressure (CPAP) devices is likely to experience a significant growth during the forecasted period.
Asia Pacific continuous positive airway pressure (CPAP) devices market is expected to grow owing to factors such growing respiratory disorders prevalence and growing geriatric population along with obesity rate. However, the high cost and associated negative effects of device is expected to restraint the growth of the market during the forecast years.
Koninklijke Philips N. V., Cardinal Health Inc, Smith’s Group plc, ResMed are among the leading companies operating in the Asia Pacific continuous positive airway pressure (CPAP) devices market.
The report segments in Asia Pacific continuous positive airway pressure (CPAP) devices market as follows:
By Product
By End User
By Country
Reasons to Buy
Based on type, the Asia Pacific continuous positive airway pressure (CPAP) devices market is further segmented into automatic and manual. The automatic segment held the larger share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. Automatic or Auto CPAP are initially used for pressure titration. Automatic titrating (measuring and adjusting) continuous positive airway pressure is also known as APAP. Auto-CPAP is set within a high and low-pressure range for the purpose of varying inhalation needs. This range is predetermined by prescribing physician. Additionally, this technology has a sensitive algorithm that allows the machine to detect the inhalation pressure which patients need with each breath. Thus, owing to above mentioned reasons, the market for automatic continuous positive airway pressure (CPAP) devices is likely to experience a significant growth during the forecasted period.
Asia Pacific continuous positive airway pressure (CPAP) devices market is expected to grow owing to factors such growing respiratory disorders prevalence and growing geriatric population along with obesity rate. However, the high cost and associated negative effects of device is expected to restraint the growth of the market during the forecast years.
Koninklijke Philips N. V., Cardinal Health Inc, Smith’s Group plc, ResMed are among the leading companies operating in the Asia Pacific continuous positive airway pressure (CPAP) devices market.
The report segments in Asia Pacific continuous positive airway pressure (CPAP) devices market as follows:
By Product
- Automatic
- Manual
By End User
- Hospital
- Emergency Health Departments
By Country
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific continuous positive airway pressure (CPAP) devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific continuous positive airway pressure (CPAP) devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Continuous Positive Airway Pressure (CPAP) Devices - Market Landscape
5. Continuous Positive Airway Pressure (CPAP) Devices Market - Key Market Dynamics
6. Continuous Positive Airway Pressure (CPAP) Devices Market - Asia Pacific Analysis
7. Continuous Positive Airway Pressure (CPAP) Devices Market- by Type
8. Continuous Positive Airway Pressure (CPAP) Devices Market Analysis by End User
9. Continuous Positive Airway Pressure (CPAP) Devices Market - Geographic Analysis
10. Impact of COVID-19 Pandemic on Asia Pacific Continuous Positive Airway Pressure (CPAP) Devices Market
11. Company Profiles
12. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Koninklijke Philips N.V.
- Cardinal Health Inc
- Smith’s Group plc
- ResMed
